Filter Results
:
(2,320)
Show Results For
-
All HBS Web
(8,220)
- Faculty Publications (2,320)
Show Results For
-
All HBS Web
(8,220)
- Faculty Publications (2,320)
health →
- 7 Jan 2014
- Other Presentation
Outcome Measurement
Keywords:
Health
Porter, Michael E. "Outcome Measurement." Health Care Strategy Seminar, Harvard Medical School, Boston, MA, January 7, 2014.
- January 2014 (Revised January 2014)
- Case
Henry Schein: Doing Well by Doing Good?
By: Rebecca Henderson, Raffaella Sadun, Aldo Sesia and Russell Eisenstat
Henry Schein Inc., a distributor of supplies to dentist, physician, and veterinary practices, had sales approaching $9 billion and employed nearly 16,000 people. The company had experienced impressive growth under the leadership of Stanley Bergman and his executive... View Details
Keywords:
Leadership Development;
Strategy Execution;
Performance Management;
Corporate Culture;
Social Responsibility;
Mergers & Acquisitions;
Joint Ventures;
Partnerships;
Health Care Industry;
Healthcare Logistics Industry;
Competitive Advantage;
Strategy;
Leadership;
Global Strategy;
Selection and Staffing;
Management Style;
Organizational Culture;
Corporate Social Responsibility and Impact;
Health Industry;
Health Industry;
China;
Europe;
United States
Henderson, Rebecca, Raffaella Sadun, Aldo Sesia, and Russell Eisenstat. "Henry Schein: Doing Well by Doing Good?" Harvard Business School Case 714-450, January 2014. (Revised January 2014.)
- January 2014
- Teaching Plan
MedImmune Ventures
By: Richard Hamermesh and Andrew Otazo
"MedImmune Ventures" highlights the problems faced by corporate venture capital firms, the challenges of investing in early-stage healthcare, and the difficulty of operating in distant markets.
View Details
Keywords:
MedImmune Ventures;
NeuProtect;
Corporate Venture Capital;
Ron Laufer;
Australia;
Starfish Ventures;
AstraZeneca;
MEVE;
Healthcare;
Startup;
Venture Capital;
Business Startups;
Health Industry;
Australia;
United States
Hamermesh, Richard, and Andrew Otazo. "MedImmune Ventures." Harvard Business School Teaching Plan 814-039, January 2014.
- 6 Jan 2014
- Other Presentation
Value Based Health Care Delivery: Welcome and Introduction
Keywords:
Health
Porter, Michael E. "Value Based Health Care Delivery: Welcome and Introduction." Value-Based Health Care Seminar, Harvard Medical School, Boston, MA, January 6, 2014.
- 6 Jan 2014
- Other Presentation
Value Based Health Care Delivery: Welcome and Introduction
Keywords:
Health
Porter, Michael E. "Value Based Health Care Delivery: Welcome and Introduction." Health Care Strategy Seminar, Harvard Medical School, Boston, MA, January 6, 2014.
- 6 Jan 2014
- Other Presentation
Value-Based Health Care Delivery
Keywords:
Health
Porter, Michael E. "Value-Based Health Care Delivery." Value-Based Health Care Seminar, Harvard Medical School, Boston, MA, January 6, 2014.
- January 2014 (Revised December 2014)
- Case
GenapSys: Business Models for the Genome
By: Richard G. Hamermesh, Joseph B. Fuller and Matthew Preble
GenapSys, a California-based startup, was soon to release a new DNA sequencer that the company's founder, Hesaam Esfandyarpour, believed was truly revolutionary. The sequencer would be substantially less expensive—potentially costing just a few thousand dollars—and... View Details
Keywords:
DNA Sequencing;
Life Sciences;
Business Model;
Innovation & Entrepreneurship;
Health Care and Treatment;
Genetics;
Business Strategy;
Health Industry;
Health Industry;
Health Industry;
Health Industry;
Health Industry;
United States
Hamermesh, Richard G., Joseph B. Fuller, and Matthew Preble. "GenapSys: Business Models for the Genome." Harvard Business School Case 814-050, January 2014. (Revised December 2014.)
- 15 Jan 2014
- Other Presentation
Value Based Health Care Delivery: Welcome and Introduction
Keywords:
Health
Porter, Michael E. "Value Based Health Care Delivery: Welcome and Introduction." Value-Based Health Care Seminar, Harvard Medical School, Boston, MA, January 15, 2014.
- 2014
- Tool
Girls Arise! Working Together for a Better Future: Negotiation Curriculum
By: Kathleen McGinn, Corinne Low and Nava Ashraf
This negotiation curriculum provides a reference guide to train Zambian girls to adopt the communication skills needed to negotiate health and education decisions with power figures in their lives.
View Details
McGinn, Kathleen, Corinne Low, and Nava Ashraf. Girls Arise! Working Together for a Better Future: Negotiation Curriculum. Tool. 2014.
- December 2013 (Revised February 2014)
- Supplement
Reinventing Brainlab (B)
By: Regina E. Herzlinger and Karol Misztal
The management of Germany's Brainlab AG, a leading provider of software-driven oncology and surgery solutions, needs to evaluate strategic options for proceeding without an exclusive hardware partner in its most profitable business segment.
View Details
Keywords:
Strategy;
Information Infrastructure;
Applications and Software;
Medical Specialties;
Health Industry;
Health Industry;
Germany
Herzlinger, Regina E., and Karol Misztal. "Reinventing Brainlab (B)." Harvard Business School Supplement 314-054, December 2013. (Revised February 2014.)
- December 2013 (Revised May 2021)
- Case
Paul Levy: Confronting a 'Corporate Campaign' (A)
Hospital CEO Paul Levy confronts an SEIU unionization drive via a "corporate campaign" aimed at undercutting the hospital's relationships with key internal and external constituencies. Having shepherded one of Boston's top teaching hospitals much of the way through a...
View Details
Keywords:
Dispute Resolution;
Corporate Campaign;
Negotiating Campaign;
Bargaining;
Health Care;
Hospitals;
Unions;
Health Care and Treatment;
Negotiation;
Strategy;
Negotiation Process;
Labor Unions;
Health Industry;
Boston
Sebenius, James K. "Paul Levy: Confronting a 'Corporate Campaign' (A)." Harvard Business School Case 914-020, December 2013. (Revised May 2021.)
- January–February 2014
- Other Article
Barriers to Health Care Innovation: Regina Herzlinger Warns That Innovators Need to Know What Obstacles They Face and How to Overcome Them
Health care in the United States and in most other developed countries is ailing, says Regina E. Herzlinger. A chaired professor of business administration specializing in health care at Harvard Business School, Herzlinger says that although the world has witnessed...
View Details
Keywords:
Healthcare;
Healthcare IT;
Innovation;
Health Care and Treatment;
Health;
Information Technology;
Innovation and Invention;
Health Industry;
Health Industry;
United States
Herzlinger, Regina E. "Barriers to Health Care Innovation: Regina Herzlinger Warns That Innovators Need to Know What Obstacles They Face and How to Overcome Them." IEEE Pulse 5, no. 1 (January–February 2014): 43–45.
- November 2013
- Teaching Note
Vitalia Franchise
Keywords:
Entrepreneurship;
Health Care and Treatment;
Ownership;
Expansion;
Health;
Health Industry;
Spain
Herzlinger, Regina E. "Vitalia Franchise." Harvard Business School Teaching Note 314-072, November 2013.
- 25 Nov 2013
- Other Presentation
Future of Healthcare Delivery
Keywords:
Health
Porter, Michael E. "Future of Healthcare Delivery." Medtronic, Minneapolis, MN, November 25, 2013.
- November 2013 (Revised January 2015)
- Case
Obamacare
By: Matthew Weinzierl and Katrina Flanagan
One vote in June, 2012, decided the fate of President Barack Obama's crowning first-term achievement: universal health insurance. Chief Justice John Roberts of the U.S. Supreme Court cast the deciding vote to uphold the keystone of the reform: the mandate to purchase...
View Details
Keywords:
Universal Health Insurance;
Adverse Selection;
Leviathan;
Courts and Trials;
Judgments;
Insurance;
Health Care and Treatment;
Government and Politics;
Health Industry;
Health Industry;
Health Industry;
United States
Weinzierl, Matthew, and Katrina Flanagan. "Obamacare." Harvard Business School Case 714-029, November 2013. (Revised January 2015.)
- 21 Nov 2013
- Other Presentation
Value-Based Health Care: From Idea to Reality
Keywords:
Health
Porter, Michael E. "Value-Based Health Care: From Idea to Reality." International Consortium for Health Outcomes Measurement (ICHOM) Annual Conference, Boston, MA, November 21, 2013.
- November 2013 (Revised June 2014)
- Case
E-Cigarettes: Marketing Versus Public Health
By: John A. Quelch and Margaret L. Rodriguez
Electronic cigarettes (e-cigarettes) were heralded by some as a healthcare game changer, enabling smokers to switch to a new product which carried lower risk of cancer. However, there were concerns about the public health risk of e-cigarettes, particularly the chance...
View Details
Keywords:
Public Health;
Tobacco;
Smoking;
Cigarettes;
Electronic Cigarettes;
Cancer;
Lung;
Lorillard;
Philip Morris;
Safety;
Technological Innovation;
Conflict of Interests;
Market Entry and Exit;
Marketing;
Health;
Advertising;
Health Industry;
Health Industry
Quelch, John A., and Margaret L. Rodriguez. "E-Cigarettes: Marketing Versus Public Health." Harvard Business School Case 514-059, November 2013. (Revised June 2014.)
- November 2013
- Teaching Note
Cialis Lifecycle Management: Lilly's BPH Dilemma
By: Elie Ofek and Natalie Kindred
Keywords:
Pharmaceuticals;
Brand Management;
Brand Equity;
Brand Positioning;
Product Management;
Product Strategy;
Pricing;
Health Care;
Health Care and Treatment;
Product Marketing;
Product Positioning;
Brands and Branding;
Marketing Strategy;
Marketing;
Product Launch;
Health Industry;
Health Industry
- November 2013
- Case
GlaxoSmithKline in China (A)
By: John A. Quelch and Margaret L. Rodriguez
Four GlaxoSmithKline employees were accused of bribing Chinese health care workers to prescribe the company's drugs. The accusations brought to light the questionable incentive structures of the Chinese health care system and the pressure on companies to adhere to...
View Details
Keywords:
Public Health;
Pharmaceuticals;
China;
Bribery;
CSR;
Hong Bao;
Health Care;
Drug;
GlaxoSmithKline;
GSK;
Witty;
Government;
Marketing;
Health;
Health Care and Treatment;
Corporate Social Responsibility and Impact;
Corporate Strategy;
Corporate Governance;
Business and Government Relations;
Ethics;
Pharmaceutical Industry;
China;
United Kingdom;
United States
Quelch, John A., and Margaret L. Rodriguez. "GlaxoSmithKline in China (A)." Harvard Business School Case 514-049, November 2013.
- November 2013 (Revised September 2015)
- Supplement
GlaxoSmithKline in China (B)
By: John A. Quelch and Margaret L. Rodriguez
In 2013, Chinese investigators detained four GSK employees for allegedly bribing health care staff to sell GSK pharmaceuticals. A month later, GSK's Asia Pacific regional president, Abbas Hussain, said the company would help identify corrupt practices. Two days later,...
View Details
Keywords:
Public Health;
Pharmaceuticals;
China;
Bribery;
CSR;
Hong Bao;
Health Care;
Drug;
GlaxoSmithKline;
GSK;
Witty;
Government;
Marketing;
Health;
Health Care and Treatment;
Corporate Social Responsibility and Impact;
Corporate Strategy;
Corporate Governance;
Business and Government Relations;
Ethics;
Pharmaceutical Industry;
China;
United Kingdom;
United States
Quelch, John A., and Margaret L. Rodriguez. "GlaxoSmithKline in China (B)." Harvard Business School Supplement 514-050, November 2013. (Revised September 2015.)